In a statement, NICE said the new guidance for Talzenna will make it an option for around 2,400 people in England and reduce ...

"The addition of relacorilant to nab-paclitaxel, a trusted and effective chemotherapy, is positioned to become a new standard ...

DMHTs sit within a broader wave of digital health technologies, helping manage a range of issues such as asthma with smart ...

J&J is predicting 2026 revenues will be between $99.5 billion and $100.5 billion, up from just over $94 billion in 2025.

Amazon has become the latest tech company to introduce an AI-powered assistant that is designed to provide health guidance ...

Roche's Gazyvaro, a drug that can restore kidney function in people living with lupus nephritis, has been cleared for use by ...

The WHO has been working over the past year to try to get the Trump administration to change course, and Director General ...

Laboratory services leader adds pharma veteran to board. Lab services giant LabCorp appointed Novartis US President Victor ...

GSK gets an entry in the list with Exdensur (depemokimab), a twice-yearly injectable IL-5 inhibitor for severe asthma, which ...

In a wide-ranging sit down during JP Morgan Week in San Francisco, Astellas' chief strategy officer Adam Pearson walked ...

Shares in ImmunityBio rose sharply after the company said it has agreed a path with the FDA that will allow it to refile for ...